Trusted News Discovery Since 2008
{{/content}}
FDA approves drug for use in fighting Alzheimer's disease
Video Credit: WCPO Cincinnati
Published on June 9, 2021 - Duration: 03:22s
FDA approves drug for use in fighting Alzheimer's disease
The FDA on Monday approved an experimental drug that aims to slow the progression of Alzheimer's disease, despite the fact that a key FDA panel late last year said that questions remain about its effectiveness.
The FDA on Monday approved the use of aducanumab in patients in the early stages of Alzheimer's.
Drugmakers Biogen and Eisai say the drug doesn't just address symptoms but actually slows the progression timeline of the disease.
WCPO 9 anchor Adrian Whitsett talks to geriatric psychiatrist Dr. Stephen Wilkes at the Mercy Health Hospital in Batavia about who this drug would benefit.
You are here
Related videos from verified sources
Groundbreaking Yet Controversial Alzheimer’s Drug Administered to First Patient 01:04
Video credit: Veuer - Published on June 17, 2021
Doctor says FDA decision was so egregious he resigned 05:36
Video credit: Bleacher Report AOL - Published on June 11, 2021
‘It’s changed my life’: Kansas man part of trial for newly approved Alzheimer’s drug 02:11
Video credit: WDAF - Published on June 11, 2021